Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

Role of Echocardiography and Cardiac Biomarkers in Early Detection of Hematopoietic Stem Cell Transplantation Associated Cardiotoxicity

Ana Carolina Oliver, MD, Roberto Superchi, MD, Superchi Federico, MD, Canabal Matilde, MD, Jubin Silvana, Lic, Carolina Errecarte, MD, Caneiro Ada, MD, Silvia Pierri, MD, Sebastian Galeano, MD, Eloisa Riva, MD, Bello Laura, MD, Regis Gai, MD, Miller Andrew, MD, Pablo J. Muxi, MD, Ricardo Fabian Mosquera, MD

Blood (2019) 134 (Supplement_1): 5688.

https://doi.org/10.1182/blood-2019-127680

Published: 2019

Journal Articles

Do Immune-Mediated TTP Patients Presenting with No Detectable ADAMTS13 Antibody Represent a Unique Clinical Phenotype?

Rebecca J Shaw, Ashley Lawrenson, Colin Downey, Kat Moss, MBBS, MRCP, Tina Dutt, PhD MBBS, BSc, FRCPath, FRCP

Blood (2018) 132 (Supplement 1): 3741.

https://doi.org/10.1182/blood-2018-99-111942

Published: 2018

Journal Articles

Adjuvant Doxycycline to Enhance Anti-Amyloid Effects: Results from the DUAL (Doxycycline to Upgrade response in AL amyloidosis) Study

Anita D'Souza, MBBS, Kathryn E Flynn, PhD, Binod Dhakal, MBBS, Saurabh Chhabra, MD, Marcelo C Pasquini, MDMS, Parameswaran Hari, MBBS, MD

Blood (2018) 132 (Supplement 1): 1999.

https://doi.org/10.1182/blood-2018-99-114783

Published: 2018

Journal Articles

Tandom Autologous Transplantation and Combined Infusion of CD19 and Bcma-Specific Chimeric Antigen Receptor T Cells for High Risk MM: Initial Safety and Efficacy Report from a Clinical Pilot Study

Xiaolan Shi, Lingzhi Yan, Jingjing Shang, Su Qu, Liqing Kang, Jin Zhou, Song Jin, Weiqin Yao, Ying Yao, Shuang Yan, Yong Liu, Guanghua Chen, Ziling Zhu, Huirong Chang, Depei Wu, MDPhD, Lei Yu, ChengCheng Fu

Blood (2018) 132 (Supplement 1): 1009.

https://doi.org/10.1182/blood-2018-99-117964

Published: 2018

Journal Articles

Distinct Biomarkers Reflect Pathophysiological Differences of Sickle Cell Disease Sub-Phenotypes: Viscosity-Vaso-Occlusion Vs. Hemolysis-Endothelial Dysfunction

Ioannis Papassotiriou, PhD, Christos Poziopoulos, MD, Katerina Larissi, MD, Alexandra Margeli, Marianna Politou, MD, Evangelos Terpos, MD, Ersi Voskaridou

Blood (2017) 130 (Supplement 1): 3520.

https://doi.org/10.1182/blood.V130.Suppl_1.3520.3520

Published: 2017

Journal Articles

Induction Therapy for AML with 90 Mg/m² Daunorubicin Results in Higher Troponin T Serum Levels in Comparison to Treatment with 60 Mg/m² Daunorubicin

Blood (2017) 130 (Supplement 1): 3901.

https://doi.org/10.1182/blood.V130.Suppl_1.3901.3901

Published: 2017

Journal Articles

99m Technetium-Hydroxy-Diphosphate Tracer (99mTcHDP) Bone Scintigraphy: An Easily Accessible, Rapid, Non-Invasive Diagnostic Tool for Cardiac Amyloidosis

Simon DJ Gibbs, MBBS, FRACP, FRCPA, Caroline Wong, MBBS, James Hare, MBBS FRACP, Hendrik Zimmet, MBBS FRACP, Jay Hocking, MBBS, FRACP, FRCPA, Anthony P Schwarer, MD MBBS (Hons), FRACP, FRCPA, Stephen B Ting, MB BS, FRACP, FRCPA, PhD

Blood (2016) 128 (22): 3557.

https://doi.org/10.1182/blood.V128.22.3557.3557

Published: 2016

Journal Articles

The Growth Differentiation Factor-15 Levels Are Increased in Patients with Compound Heterozygous Sickle Cell and Beta-Thalassemia, Correlate with Hepcidin-25/Ferritin Molar Ratio and with Markers of Hemolysis, Endothelial Dysfunction and Angiogenesis

Ioannis Papassotiriou, PhD, Katerina Larrisi, MD, Alexandra Margeli, PhD, Dimitrios Christoulas, Maria Dimopoulou, MD, Vaughn Ostland, PhD, Christos Poziopoulos, Mark Westerman, PhD, Marianna Politou, MD, Ersi Voskaridou, MD, Evangelos Terpos, MD PhD

Blood (2016) 128 (22): 3646.

https://doi.org/10.1182/blood.V128.22.3646.3646

Published: 2016

Journal Articles

Analysis of Clinical Features, Laboratory Characteristics and Therapeutic Outcome in Patients with Thrombotic Thrombocytopenic Purpura Treated at King Fahad Medical City, Riyadh, Saudi Arabia

Shahid Iqbal, MBBS, FCPS, MRCP, Syed Ziauddin A. Zaidi, MBBS, FRCP, FCPS, FRCPath, FACP, Ibraheem H. Motabi, MD, Nawal Faiez Alshehry, MD SBIM, SBAH, Mubarak S. AlGhamdi, MD, Samer Mudaibigh, MD SBIM, SBAH, Atta Munawar Gill, MBBS, MRCPI, SBAH, Karrar ElHussein, MBBS, MRCP, May Al-Moshary, MD KSFH, Imran Pukhta, MBBS, MD, Abdul Rehman Zia Zaidi, MBBS, Imran K Tailor, MBBS, MD FRCP, FRCPath, Muhammad Nabulsiah, BSc, RN, Belal Albtoosh, BSc, RN

Blood (2016) 128 (22): 4915.

https://doi.org/10.1182/blood.V128.22.4915.4915

Published: 2016

Journal Articles

Plakin Family Autoantibodies in Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation As Useful Biomarkers and the Target for Rituximab Therapy

Eri Nishikawa, MD PhD, Yoshinao Muro, MD PhD, Nozomu Kawashima, MD PhD, Shinsuke Kataoka, MD, Motoharu Hamada, MD, Daisuke Ichikawa, MD, Daiei Kojima, MD, Norihiro Murakami, MD, Kyogo Suzuki, MD, Yuko Sekiya, MD, Yusuke Okuno, MD PhD, Rieko Taniguchi, MD, Atsushi Narita, MD PhD, Hideki Muramatsu, MD PhD, Nobuhiro Nishio, MD PhD, Asahito Hama, MD PhD, Seiji Kojima, MD PhD, Masashi Akiyama, MD PhD, Yoshiyuki Takahashi, MD PhD

Blood (2016) 128 (22): 3432.

https://doi.org/10.1182/blood.V128.22.3432.3432

Published: 2016

Journal Articles

In Patients with Light-Chain (AL) Amyloidosis Myocardial Contraction Fraction (MCF) Is a Simple, but Powerful Prognostic Measure That Can be Calculated from a Standard Echocardiogram (ECHO)

Blood (2015) 126 (23): 1774.

https://doi.org/10.1182/blood.V126.23.1774.1774

Published: 2015

Journal Articles

Bortezomib Containing Regimens Are Highly Effective for Systemic AL Amyloidosis: Experience from a Single Center

Victor H Jimenez Zepeda, MD, Peter Duggan, MD, Paola E. Neri, MD PhD, Nizar J Bahlis, MD

Blood (2014) 124 (21): 4743.

https://doi.org/10.1182/blood.V124.21.4743.4743

Published: 2014

Journal Articles

Growth Differentiation Factor-15 in Patients with Light Chain (AL) Amyloidosis Has Independent Prognostic Significance and Adds Prognostic Information Related to Risk of Early Death and Renal Outcomes

Efstathios Kastritis, MD, Ioannis Papassotiriou, PhD, Evangelos Terpos, Athanassios Akalestos, Erasmia Psimenou, Filia Apostolakou, Maria Roussou, Maria Gavriatopoulou, Elisavet Kaldara, Evangelos Eleutherakis-Papaiakovou, Despoina Kalapanida, Constantinos Pamboucas, Evangelos Kostis, Sofoklis Kontogiannis, Savvas Th. Toumanidis, Ioannis Boletis, Meletios A. Dimopoulos

Blood (2014) 124 (21): 306.

https://doi.org/10.1182/blood.V124.21.306.306

Published: 2014

Journal Articles

Elevated High Sensitivity Troponin T (HsTnT) during Front-Line Therapy with Cyclophosphamide, Doxorubicin, Vincristine and Prednisone +/- Rituximab (CHOP+/-R) or Cyclophosphamide, Epirubicin, Vincristine and Prednisone +/- Rituximab (CEpOP+/-R) Correlates with a Decline in Left Ventricular Ejection Fraction (LVEF) in Patients with Aggressive B-Cell Lymphoma: Results from a Randomized Prospective Clinical Trial NCT00854568

Kai Xue, MD, Juan J Gu, PhD, Qunling Zhang, MD, Xiaojian Liu, MD, Jiachen Wang, Jianfeng Luo, Francisco J. Hernandez-Ilizaliturri, MD, Stanley F. Fernandez, MD, Myron S. Czuczman, MD, Junning Cao, MD Associate Professor, Xiaonan Hong, MD, Ye Guo, MD

Blood (2014) 124 (21): 3041.

https://doi.org/10.1182/blood.V124.21.3041.3041

Published: 2014

Journal Articles

Increased Von Willebrand Factor and High Circulating Placental Growth Factor Correlate with Inflammation and Iron Overload in Patients with Compound Heterozygous Sickle Cell and Beta-Thalassemia

Ersi Voskaridou, MD, Katerina Larrisi, Marianna Politou, Veroniki Komninaka, Filia Apostolakou, Chrysanthi Skevaki, Maria Giannaki, Ioannis Papassotiriou, Evangelos Terpos

Blood (2014) 124 (21): 1392.

https://doi.org/10.1182/blood.V124.21.1392.1392

Published: 2014

Journal Articles

High Dose Melphalan Followed By Autologous Stem Cell Transplant in AL Amyloidosis: a Single-Center Experience

Mariella D'Adda, MD, Francesca Schieppati, MD, Samantha Ferrari, MD, Claudia Crippa, MD, Annalisa Peli, MD, Alessandro Re, MD, Enrico Morello, MD, Paola Tozzi, PharmD, Vincenza Orlando, PharmD, Giuseppe Rossi, MD

Blood (2014) 124 (21): 5909.

https://doi.org/10.1182/blood.V124.21.5909.5909

Published: 2014

Journal Articles

Autologous Stem Cell Transplantation In Immunoglobulin Light Chain Amyloidosis With Factor X Deficien

Stefan F Cordes, MD, PhD, Morie A Gertz, M.D., Francis K Buadi, MD, Yi Lin, MDPhD, Martha Q Lacy, MD, Prashant Kapoor, MD, Shaji K Kumar, MD, Arleigh McCurdy, MD, Angela Dispenzieri, MD, David Dingli, M.D., Ph.D., Suzanne R Hayman, MD, William J. Hogan, MBChB, Rajiv K Pruthi, MBBS

Blood (2013) 122 (21): 2151.

https://doi.org/10.1182/blood.V122.21.2151.2151

Published: 2013

Journal Articles

Autologous Stem Cell Transplantation Improves Survival For High Risk Cardiac Amyloidosis

Piyanuch Kongtim, MD, Muzaffar H. Qazilbash, MD, Jatin J. Shah, M.D., Robert Z. Orlowski, M.D., Ph.D., Amir Hamdi, MD, Nina Shah, MD, Qaiser Bashir, MD, Michael Wang, MD, Richard E Champlin, MD, Simrit Parmar, MD

Blood (2013) 122 (21): 3341.

https://doi.org/10.1182/blood.V122.21.3341.3341

Published: 2013

Journal Articles

Soluble ST2 (sST2) Is a Novel Valuable Prognostic Marker Among Patients With Immunoglobulin Light Chain (AL) Amyloidosis

Angela Dispenzieri, MD, Amy K. Saenger, M.D., Shaji K. Kumar, MD, Morie A. Gertz, M.D., Martha Q Lacy, MD, Francis Buadi, MD, Suzanne R Hayman, MD, Nelson Leung, MD, Steven R Zeldenrust, MD, PhD, Arleigh McCurdy, MD, Robert Kyle, MD, MACP, David Dingli, M.D., Ph.D., Prashant Kapoor, MD, Yi Lin, MDPhD, Stephen J. Russell, MD, PhD, Ronald S. Go, MD, Allan S. Jaffe, M.D.

Blood (2013) 122 (21): 3095.

https://doi.org/10.1182/blood.V122.21.3095.3095

Published: 2013

Journal Articles

Survival After Second, Third, and Fourth Line Therapy Better Than Expected in Patients with Previously Treated AL Amyloidosis Who Were Not Transplant Candidates At Diagnosis.

Girindra G Raval, MD, Morie A Gertz, Martha Q Lacy, MD, Suzanne R Hayman, MD, Shaji K. Kumar, MD, Francis K Buadi, M.D., John A. Lust, MD, PhD, Steven Zeldenrust, MD, David Dingli, M.D., Ph.D., Robert L Hall, RN, CNP, Lisa Hwa, RN, CNP, Yi Lin, MD, Prashant Kapoor, MD, Thomas E. Witzig, MD, Robert A. Kyle, MD, Stephen Russell, MD, PhD, Nelson Leung, MD, S. Vincent Rajkumar, MD, Angela Dispenzieri, MD

Blood (2012) 120 (21): 946.

https://doi.org/10.1182/blood.V120.21.946.946

Published: 2012

NARROW

Role of Echocardiography and Cardiac Biomarkers in Early Detection of Hematopoietic Stem Cell Transplantation Associated Cardiotoxicity

Do Immune-Mediated TTP Patients Presenting with No Detectable ADAMTS13 Antibody Represent a Unique Clinical Phenotype?

Adjuvant Doxycycline to Enhance Anti-Amyloid Effects: Results from the DUAL (Doxycycline to Upgrade response in AL amyloidosis) Study

Tandom Autologous Transplantation and Combined Infusion of CD19 and Bcma-Specific Chimeric Antigen Receptor T Cells for High Risk MM: Initial Safety and Efficacy Report from a Clinical Pilot Study

Distinct Biomarkers Reflect Pathophysiological Differences of Sickle Cell Disease Sub-Phenotypes: Viscosity-Vaso-Occlusion Vs. Hemolysis-Endothelial Dysfunction

Induction Therapy for AML with 90 Mg/m² Daunorubicin Results in Higher Troponin T Serum Levels in Comparison to Treatment with 60 Mg/m² Daunorubicin

99m Technetium-Hydroxy-Diphosphate Tracer (99mTcHDP) Bone Scintigraphy: An Easily Accessible, Rapid, Non-Invasive Diagnostic Tool for Cardiac Amyloidosis

The Growth Differentiation Factor-15 Levels Are Increased in Patients with Compound Heterozygous Sickle Cell and Beta-Thalassemia, Correlate with Hepcidin-25/Ferritin Molar Ratio and with Markers of Hemolysis, Endothelial Dysfunction and Angiogenesis

Analysis of Clinical Features, Laboratory Characteristics and Therapeutic Outcome in Patients with Thrombotic Thrombocytopenic Purpura Treated at King Fahad Medical City, Riyadh, Saudi Arabia

Plakin Family Autoantibodies in Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation As Useful Biomarkers and the Target for Rituximab Therapy

In Patients with Light-Chain (AL) Amyloidosis Myocardial Contraction Fraction (MCF) Is a Simple, but Powerful Prognostic Measure That Can be Calculated from a Standard Echocardiogram (ECHO)

Bortezomib Containing Regimens Are Highly Effective for Systemic AL Amyloidosis: Experience from a Single Center

Growth Differentiation Factor-15 in Patients with Light Chain (AL) Amyloidosis Has Independent Prognostic Significance and Adds Prognostic Information Related to Risk of Early Death and Renal Outcomes

Increased Von Willebrand Factor and High Circulating Placental Growth Factor Correlate with Inflammation and Iron Overload in Patients with Compound Heterozygous Sickle Cell and Beta-Thalassemia

High Dose Melphalan Followed By Autologous Stem Cell Transplant in AL Amyloidosis: a Single-Center Experience

Autologous Stem Cell Transplantation In Immunoglobulin Light Chain Amyloidosis With Factor X Deficien

Autologous Stem Cell Transplantation Improves Survival For High Risk Cardiac Amyloidosis

Soluble ST2 (sST2) Is a Novel Valuable Prognostic Marker Among Patients With Immunoglobulin Light Chain (AL) Amyloidosis

Survival After Second, Third, and Fourth Line Therapy Better Than Expected in Patients with Previously Treated AL Amyloidosis Who Were Not Transplant Candidates At Diagnosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only